SCHEMBL1720487

SCHEMBL1720487

CC(=O)Cc1nc(Cl)cc(Cl)n1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 2/20 0.41
HTT P42858 3/20 0.39
S1PR2 O95136 1/20 0.38
ALDH1A1 P00352 8/20 0.37
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 4/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28989534 0.78 HSP90AB1 (0.44) NPC1RAB9AS1PR2ALDH1A1LMNA
SCHEMBL1719917 0.76 HTT (0.67) NPC1RAB9AHTTALDH1A1LMNA
SCHEMBL24738809 0.75 KDM4E (0.50) RAB9AHTTALDH1A1LMNASMN1; SMN2
SCHEMBL11000782 0.75 ALDH1A1 (0.34) HTTS1PR2ALDH1A1SMN1; SMN2MAPK1
SCHEMBL6034188 0.74 ALDH1A1 (0.41) S1PR2ALDH1A1LMNACYP3A4KDM4E
SCHEMBL9460630 0.72 HTT (0.52) HTTALDH1A1LMNASMN1; SMN2MAPK1
SCHEMBL1720666 0.71 CYP1A2 (0.52) NPC1RAB9AHTTALDH1A1LMNA
SCHEMBL16503642 0.70 SMN1; SMN2 (0.42) NPC1RAB9AHTTS1PR2ALDH1A1
SCHEMBL9461180 0.70 ALDH1A1 (0.44) ALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL21434181 0.69 RECQL (0.38) HTTS1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1334968-B1 PROCESS FOR PRODUCING SUBSTITUTED ANILINE COMPOUND IHARA CHEMICAL IND CO (JP) 2012-01-11 EP disclosed
US-7820861-B2 chemical intermediate for a sulfonanilide of 4,6-dimethoxypyrmidine derivative herbicide IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2010-10-26 US disclosed
EP-2025665-B1 Process for producing substituted aniline compound IHARA CHEMICAL IND CO (JP) 2010-09-15 EP disclosed
US-7531654-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-05-12 US disclosed
US-7521555-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-04-21 US disclosed
US-7504503-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-03-17 US disclosed
EP-2025665-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2009-02-18 EP disclosed
US-7271263-B2 Process for production of substituted aniline compound IHARA CHEMICAL INDUSTRY, CO., LTD. (JP) 2007-09-18 US disclosed
US-20070213561-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20070213532-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20070213533-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20060281765-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-12-14 US disclosed
US-20040034251-A1 Process for production of substituted aniline compound 1HARA CHEMICAL INDUSTRY CO., LT.D. (JP) 2004-02-19 US disclosed
EP-1334968-A1 PROCESS FOR PRODUCING SUBSTITUTED ANILINE COMPOUND Ihara Chemical Industry Co., Ltd. (JP) 2003-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034251-A1 Process for production of substituted aniline compound NAT1, CBR3, AADAC NPC1 2795/4885RAB9A 2192/4885HTT 2412/4885
US-20070213561-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 NPC1 3420/4885RAB9A 3060/4885HTT 1962/4885
US-20060281765-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 NPC1 3420/4885RAB9A 3060/4885HTT 1962/4885
US-20070213532-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 NPC1 3420/4885RAB9A 3060/4885HTT 1962/4885
US-20070213533-A1 Process for producing substituted aniline compound AADAC, NAT1, CBR3 NPC1 3387/4885RAB9A 3398/4885HTT 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.